TITLE

The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria

AUTHOR(S)
Khani, B.; Mehrabian, F.
PUB. DATE
June 2014
SOURCE
Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p73
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Introduction: This study aimed to determine the prevalence of polycystic ovary syndrome (PCOS) in Iranian women based on different diagnostic criteria. Materials and Methods: This cross-sectional study was conducted in 2009 in Isfahan, Iran among females referred to the mandatory pre-marriage screening clinic. Menstrual irregularity was assessed as the presence of chronic amenorrhea or a menstrual cycle length of less than 21 days or more than 35 days, or more than four days of variation between cycles. Clinical hyperandrogenism was assessed as the self-reported degree of hirsutism using the modified Ferriman Gallwey (mF-G) scoring method based on a chart displaying degree of hair growth in nine regions. Those participants who reported menstrual irregularity and/or who had an mF-G score of >8 were invited for a clinical examination. Those who did not have these criteria were not further evaluated and were deemed not to have PCOS. Participants with abnormal findings underwent blood test and abdominal sonography of their ovaries. In those with hirsutism, serum was obtained on the 22nd-24' day of the cycle for the measurement of progesterone; free testosterone was measured in those with menstrual irregularity. Results: The estimated prevalence of PCOS was 7% based on the NIH criteria, 15.2% under the Rotterdam criteria, and 7.92% according to the AES criteria. Conclusion: The Rotterdam prevalence estimates were double those obtained with the NIH criteria. This study can be used for international comparisons because it was conducted on a representative sample of females using different criteria for the definition of PCOS.
ACCESSION #
96841661

 

Related Articles

  • Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).  // Human Reproduction;Jan2004, Vol. 19 Issue 1, p41 

    Since the 1990 NIH-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop...

  • Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review. M. van Wely; N. Bayram; F. van der Veen // Human Reproduction;Jun2003, Vol. 18 Issue 6, p1143 

    This paper is based on a Cochrane review published in The Cochrane Library, issue 2, 2001 (see www.CochraneLibrary. net for information) with permission from The Cochrane Collaboration and Update Software. Cochrane reviews are regularly updated as new evidence emerges and in response to comments...

  • Prevalence of polycystic ovaries among patients with hirsutism and menstrual abnormalities. Rasool, Shazia; Dar, Lubna Riaz; Hameed, Abdul // Journal of Pakistan Association of Dermatologists;Jul2011, Vol. 21 Issue 3, p174 

    Background Polycystic ovaries are considered to be the most frequent cause of hirsutism with its prevalence of 10% of woman of reproductive age group. Polycystic ovarian syndrome (PCOS) reflects multiple potential etiologies and variable clinical presentations Objectives To investigate the...

  • Transvaginal Hydrolaparoscopic Ovarian Drilling for Infertile Women with Polycystic Ovary Syndrome. Shibahara, Hiroaki; Hirano, Yuki; Suzuki, Mitsuaki // Current Women's Health Reviews;2006, Vol. 2 Issue 1, p91 

    Polycystic ovary syndrome (PCOS) is a syndrome of ovarian dysfunction showing cardinal features of hyperandrogenism and polycystic ovarian morphology. It is one of the most common reproductive endocrine disorders in young adult women, showing clinical signs of menstrual disorder, anovulation,...

  • Severe Adolescent Menorrhagia due to Cervical Fibroid. Majumdar, Abha; Singh, Tejshree // Journal of South Asian Federation of Obstetrics & Gynecology;Jan-Apr2010, Vol. 2 Issue 1, p65 

    A rare case of severe menorrhagia in a young girl with polycystic ovarian syndrome (PCOS) is presented. On thorough investigations (blood tests and ultrasound) nothing substantial came up, hence ultimately pelvic examination under anesthesia was undertaken, which uncovered a cervical polyp 2.5...

  • Polycystic ovary syndrome in adolescence—a therapeutic conundrum. Homburg, Roy; Lambalk, Cornelius B. // Human Reproduction;Vol. 19 Issue 5, p1039 

    The polycystic ovary syndrome (PCOS) often presents in adolescence with menstrual disorders, acne and hirsutism. The early diagnostic signs are sometimes dismissed as ‘normal’ changes of adolescence, and the opportunity to save the teenager from the stigmata of the syndrome is...

  • Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Laitinen, J; Taponen, S; Martikainen, H; Pouta, A; Millwood, I; Hartikainen, A-L; Ruokonen, A; Sovio, U; McCarthy, M I; Franks, S; Jarvelin, M R // International Journal of Obesity & Related Metabolic Disorders;Jun2003, Vol. 27 Issue 6, p710 

    OBJECTIVE: To study the association between body size from birth to adulthood and self-reported symptoms of polycystic ovary syndrome (PCOS), particularly hirsutism and menstrual disturbances. DESIGN: Longitudinal, population-based study of a cohort of women born in 1966 in northern Finland. The...

  • Metformin treatment is effective in obese teenage girls with PCOS. Vincenzo De Leo // Human Reproduction;Sep2006, Vol. 21 Issue 9, p2252 

    BACKGROUND: Polycystic ovary syndrome (PCOS) is the most frequent cause of menstrual disorders in teenage girls. Little information is available about the effects of metformin in adolescent girls with PCOS and its dose and its efficacy in regulating menstrual cyclicity and hyperandrogenic...

  • Irregular cycles and steroid hormones in polycystic ovary syndrome. Suhail A.R. Doi; Mona Al-Zaid; Philip A. Towers; Christopher J. Scott; Kamal A.S. Al-Shoumer // Human Reproduction;Sep2005, Vol. 20 Issue 9, p2402 

    BACKGROUND: This cross-sectional study was undertaken to evaluate the factors that relate to menstrual status (oligo-amenorrhoea versus eumenorrhoea) in polycystic ovary syndrome (PCOS). METHODS: A total of 234 women with clinical and biochemical features suggestive of PCOS underwent metabolic...

  • Period problems: disorders of menstruation in adolescents. Peacock, A.; Alvi, N. S.; Mushtaq, T. // Archives of Disease in Childhood;Jun2012, Vol. 97 Issue 6, p554 

    Adolescence is a time of great psychological and physical change. In the UK, girls enter puberty around the age of 10 years with a median age of menarche of 12.9 years; thereafter, it may be several years before regular menstrual cycles are established. Variations in the type and the frequency...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics